The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Is BPC 157 Banned? Oral vs. Injectable Forms Explained The peptide problem: Hype is outrunning the evidence Q&A: Should you trust trending peptide injections? Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,